Bio:Michal Kahan has held various positions within several high technology companies over the last 25+ years. Michal has experience in R&D, Marketing and Sales and Management.

Professional highlights include the following:

CEO at Lev El Diagnostics of Heart Disease since 2011.

Lev El Diagnostics of Heart Disease is a privately-held medical device company which developed and started marketing its flag-ship product HeartTrends™. HeartTrends is focused on detection of myocardial Ischemia related to coronary artery disease.

Prior to Lev El Diagnostics of Heart Diseases, Michal was a co-founder and VP of sales and product marketing at Dune Networks, a semi-conductor company.

Dune Networks developed the most advanced and highest capacity silicon for the networking market. It was acquired by Broadcom at a price of $205M, after: almost 10 years from foundation, developing 5 generations of silicon, and achieving $30M revenue, while competing face-to-face with the “Giant” Broadcom.

Before transferring to the semiconductor (hardware) market, Michal worked at software companies in various positions: Daisy (R&D, 5 years), Tecnomatix (R&D and Product Marketing, 5 years), Comverse (VP Marketing, 3 years).

Michal holds a BSc in Mathematics and Computer Science from Tel Aviv University, and completed an MBA cum laude at The International School of Management (TISOM, Israel) Michal loves sports, specifically jogging and has already participated in two half-marathons, the latest in Madrid, April, 2014.

Michal is an IVN (Israel Venture Network) member serving as a mentor to two social businesses.